Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety (Q39933788)
Jump to navigation
Jump to search
scientific article published on 8 March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety |
scientific article published on 8 March 2016 |
Statements
1 reference
Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety (English)
1 reference
U A Matulonis
1 reference
R T Penson
1 reference
S M Domchek
1 reference
B Kaufman
1 reference
R Shapira-Frommer
1 reference
M W Audeh
1 reference
S Kaye
1 reference
L R Molife
1 reference
K A Gelmon
1 reference
J D Robertson
1 reference
H Mann
1 reference
T W Ho
1 reference
R L Coleman
1 reference
8 March 2016
1 reference
1 reference
27
1 reference
6
1 reference
1013-1019
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference